Cell Therapeutics, Inc. - CTIC- Profile

Home » Directory » Pharmaceuticals & Biotechnology » Critical Therapies » Cancer » Cell Therapeutics, Inc. » Profile

Website: http://www.cticseattle.com

Phone: +1 206 282-7100
Address:
501 Elliott Avenue West
Seattle, WASHINGTON 98119

Company Description
Cell Therapeutics, Inc.. The Group's principal activity is to develop, acquire and market treatments for cancer. The products of the Group include TRISENOX that is marketed for patients with a type of blood cell cancer called acute promyelocytic leukemia, or APL. The FDA to treat patients who have relapsed or refractory acute promyelocytic leukemia has approved TRISENOX, a pharmaceutical grade arsenic product. The principal products of the Group are TRISENOX, PG-TXL, PG- CPT and CT-2584.
Key People
Chairman Dr. Max E. Link
President & Chief Executive Dr. James A. Bianco
Executive Vice President Finance & Chief Financial Officer Louis A. Bianco
Secretary Michael J. Kennedy

Related Business Topics
click here
A-Z Cell Therapeutics, Inc. Provider Directory
0-9 | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
C
Cell Therapeutics
cti is committed to discovering, acquiring, developing and bringing to market innovative treatments for cancer.
www.cticseattle.com
Breaking News

More Cell Therapeutics News

2000% Gain on VKNG
This Penny Stock soar 2000% Join today for Free to Profit
www.pennystockpic.com
Cell Therapeutics
The potential to change the way anti-cancer drugs are developed.
www.celltherapeutics.com
Electrifying CTIC Rumor
Find Out The Shocking CTIC Rumor Why CTIC May Run 1000%.
BestDamnPennyStocks.com/CTIC

Overview  |  Profile  |  News  |  Quote & Financials